Sehgal, Vasudha
36  Ergebnisse:
Personensuche X
?
5

OA06.07 Evaluating Genomic Signatures Predicting Veliparib ..:

He, Lei ; Huang, Xin ; Sun, Yan...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S267-S268 , 2017
 
?
6

Novel biomarkers of nasopharyngeal carcinoma metastasis ris..:

Xu, Tao ; Su, Bojin ; Huang, Peiyu...
PROTEOMICS – Clinical Applications.  11 (2016)  5-6 - p. , 2016
 
?
 
?
11

Estimation of the rate and effect of new beneficial mutatio..:

Zhang, Wei ; Sehgal, Vasudha ; Dinh, Duy M....
Theoretical Population Biology.  81 (2012)  2 - p. 168-178 , 2012
 
?
13

Impact of homologous recombination status and responses wit..:

Swisher, Elizabeth M ; Aghajanian, Carol ; O'Malley, David M...
Swisher , E M , Aghajanian , C , O'Malley , D M , Fleming , G F , Kaufmann , S H , Levine , D A , Birrer , M J , Moore , K N , Spirtos , N M , Shahin , M S , Reid , T J , Friedlander , M , Steffensen , K D , Okamoto , A , Sehgal , V , Ansell , P J , Dinh , M H , Bookman , M A & Coleman , R L 2022 , ' Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study ' , Gynecologic Oncology , vol. 164 , no. 2 , pp. 245-253 . https://doi.org/10.1016/j.ygyno.2021.12.003.  , 2022
 
?
15

Veliparib Plus Carboplatin and Paclitaxel Versus Investigat..:

Govindan, Ramaswamy ; Lind, Mike ; Insa, Amelia...
Govindan , R , Lind , M , Insa , A , Khan , S A , Uskov , D , Tafreshi , A , Guclu , S , Bar , J , Kato , T , Lee , K H , Nakagawa , K , Hansen , O , Biesma , B , Kundu , M G , Dunbar , M , He , L , Ansell , P , Sehgal , V , Huang , X , Glasgow , J & Bach , B A 2022 , ' Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer ' , Clinical Lung Cancer , vol. 23 , no. 3 , pp. 214-225 . https://doi.org/10.1016/j.cllc.2022.01.005.  , 2022
 
1-15